Seer

I led the rebrand of Seer to power their 2020 IPO and reflect the ever-changing nature of the proteome. Seer’s proprietary nanoparticle technology gives researchers access to previously undetectable proteins, opening new pathways for understanding disease. The brand system was designed to mirror this constant motion. Rounded and linear logo forms express scientific complexity, while a custom typeface references the curves found in proteomic data. A confident color palette breaks from biotech convention to signal progress. From IPO materials to product toolkits, the identity was built to evolve with the science and scale across every audience touchpoint.